mjs106

Matthias Schnell, PhD

Contact Dr. Schnell

1020 Locust Street
Room 309
Philadelphia, PA 19107

(215) 503-4634

Most Recent Peer-reviewed Publications

  1. Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity
  2. Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract
  3. Current vaccine strategies against SARS-CoV-2: Promises and challenges
  4. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model
  5. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
  6. A strategy to detect emerging non-delta sars-cov-2 variants with a monoclonal antibody specific for the n501 spike residue
  7. Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates
  8. SARS-CoV-2 vaccines — the biggest medical research project of the 21st century
  9. Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model
  10. Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
  11. Rhabdoviruses as vectors for vaccines and therapeutics
  12. Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups
  13. Identification and characterization of a small-molecule rabies virus entry inhibitor
  14. Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus (npj Vaccines, (2019), 4, 1, (15), 10.1038/s41541-019-0109-5)
  15. Rabies-based vaccine induces potent immune responses against Nipah virus
  16. Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge
  17. Persistence of Lassa Virus Associated with Severe Systemic Arteritis in Convalescing Guinea pigs (Cavia porcellus)
  18. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies
  19. Avoiding preventable deaths: The scourge of counterfeit rabies vaccines
  20. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses
  21. A recombinant rabies virus expressing the marburg virus glycoprotein is dependent upon antibody-mediated cellular cytotoxicity for protection against marburg virus disease in a murine model
  22. Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
  23. New developments in rabies vaccination
  24. Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons
  25. The spread and evolution of rabies virus: Conquering new frontiers